Marc Martinez Llordella

Company: Quell Therapeutics

Job title: Co-founder & Vice President - Biology

Seminars:

Development of CAR-Treg Therapies to Induce Immune Tolerance – Path to the Clinic 1:00 pm

• Description of Quell Therapeutic’s platform to generate CAR-Treg products with enhanced safety and efficacy • Analysis of the current outcomes from the clinical experience with CAR-Tregs in liver transplantation NEW DATARead more

day: Day Two Track B, PM